Wale, J 
ORCID: 0000-0002-9210-029X and Rowlands, S
(2021)
'The ethics of state-sponsored and clinical promotion of long-acting reversible contraception.'
BMJ Sexual & Reproductive Health, 47.
e11.
ISSN 2515-1991
|
Text
13339.pdf - Accepted Version Repository Terms Apply. Download (1MB) | Preview |
Abstract
Objectives:- To review ethical aspects of the promotion and provision of long-acting reversible contraception (LARC). Specifically, to examine (1) the tension between informational exchange and the active promotion of LARC methods to new and existing contraceptive users by healthcare professionals; and (2) the distinct ethical issues arising from the promotion of LARC methods by state-sponsored actors and healthcare professionals. Methods:- Narrative review and ethical analysis. Findings:- There is an ethical difference between raising awareness/informational provision and actively promoting or prioritising specific contraceptive methods. It matters whether the policy choice is made, or the promotional activity about contraception is undertaken, by individual healthcare professionals at a local level or by more remote state-sponsored actors, because the relationship between the promoter and the (potential) contraceptive user is of a different kind. Imposing a dual responsibility upon healthcare professionals for raising awareness/informational exchange and the active promotion of LARC creates an unnecessary tension and barrier for the delivery of patient-centred care. Conclusions:- This review highlights the need for ethical reflection on the central role of the promoting agent and the distinction between facilitating informational awareness and active promotion of LARC. LARC methods should not be prioritised in isolation and without regard to the wider implications of public promotion. A balanced narrative and information-sharing programme that respects the individual interests of each contraceptive user is called for, especially in direct professional/service user relationships. No assumption should be made that user decision-making will necessarily be determined and influenced solely by the relative effectiveness of the contraceptive method.
| Item Type: | Article |
|---|---|
| Note: | This article was first published online in June 2020 and included in an issue in July 2021. |
| Divisions: | Bath Business School |
| Identification Number: | https://doi.org/10.1136/bmjsrh-2020-200630 |
| Date Deposited: | 23 Jul 2020 13:25 |
| Last Modified: | 30 Nov 2023 19:46 |
| URI / Page ID: | https://researchspace.bathspa.ac.uk/id/eprint/13339 |
 |
Request a change to this item or report an issue |
 |
Update item (repository staff only) |
Tools
Tools
